glp 1 lower inflammation GLP-1 Receptor Agonists Reduce Myths & Facts: GLP-1 Drugs

These agents enhance glucose-dependent insulin secretion from pancreatic beta cells, suppress inappropriate glucagon release, slow gastric emptying, and promote satiety through central nervous system pathways

Much of what patients read online reflects animal studies or anecdotal reports not established clinical efficacy in humans

One preclinical study finding BPC-157 inhibited melanoma provides limited reassurance, but comprehensive human oncological safety data would require extensive trials that no one has conducted

Electrolyte disturbances represent another important consideration

Bondaruc et al 2016)

Foley continues to monitor compounded GLP-1 medication developments in Ohio and across the country